Mitral Valve Annuloplasty Rings Market is driven by rising heart disease prevalence
X-linked Hypophosphatemia (XLH) is a rare hereditary disorder characterized by excessive phosphate excretion and defective bone mineralization. Treatment paradigms have evolved from conventional phosphate and vitamin D supplementation to novel targeted therapies such as burosumab, a monoclonal antibody that inhibits FGF23. These advanced treatments offer significant improvements in bone health,...
0 Commentarios 0 Acciones 103 Views 0 Vista previa